Gastroenterology

High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag



High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag

Source link

Related posts

Researchers emphasize need for baby boomers to get tested for hepatitis C

Newsemia

Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis

Newsemia

Surface Grafted MSI-78A Antimicrobial Peptide has High Potential for Gastric Infection Management

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World